EGF and cancer: ERK and PI3K/AKT are critical components of EGF-activated signaling, which has been associated with human cancer EMT (Wudtiwai et al., 2018; Jiang et al., 2019; Park et al., 2019; Yang et al., 2019; Yoo et al., 2019).